Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challenges.
Saved in:
| Title: | Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challenges. |
|---|---|
| Authors: | Sayyed A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; Department of Oncology, Schulich School of Medicine & Dentistry, Western University, London, Canada., Novitzky-Basso I; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University of Toronto, Toronto, Canada., Remberger M; KFUE, Uppsala University Hospital and IMV, Uppsala University, Uppsala, Sweden., Clarke S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada., Chen C; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada., Al-Shaibani E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University of Toronto, Toronto, Canada., Kim DDH; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University of Toronto, Toronto, Canada., Viswabandya A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University of Toronto, Toronto, Canada., Kumar R; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University of Toronto, Toronto, Canada., Lam W; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University of Toronto, Toronto, Canada., Law AD; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University of Toronto, Toronto, Canada., Gerbitz A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University of Toronto, Toronto, Canada., Pasic I; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University of Toronto, Toronto, Canada., Michelis FV; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University of Toronto, Toronto, Canada., Mattsson J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. jonas.mattsson@uhn.ca.; University of Toronto, Toronto, Canada. jonas.mattsson@uhn.ca.; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Toronto, Canada. jonas.mattsson@uhn.ca. |
| Source: | Bone marrow transplantation [Bone Marrow Transplant] 2025 Sep; Vol. 60 (9), pp. 1236-1242. Date of Electronic Publication: 2025 Jun 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
